Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Rangers Rumors

Rangers Acquire Clayton Blackburn From Giants

By | at

The Rangers have acquired right-hander Clayton Blackburn from the Giants for minor league infielder Frandy De La Rosa, per announcements from both teams.

It’s no surprise that San Francisco found a taker for the 24-year-old Blackburn, who began generating interest after the Giants designated him for assignment Tuesday. Baseball America ranked Blackburn among the Giants’ 10 best prospects from 2012-15, including sixth in 2014, but his stock dropped with a disappointing 2016. In 136 1/3 innings, Blackburn logged a 4.36 ERA, 6.67 K/9 and 2.31 BB/9. That came after a far better showing in 2015, when he pitched to a 2.85 ERA – with 7.24 K/9 and 2.34 BB/9 – in 123 frames. The optionable Blackburn figures to provide starting depth for Texas, which has already sent him to Triple-A.

De La Rosa, meanwhile, has now been part of two deals since signing with the Cubs as an international free agent from the Dominican Republic in 2013 (Chicago shipped him to the Rangers for righty Spencer Patton in 2015). At the time of the first swap involving De La Rosa, Baseball America’s Vince Lara-Cinisomo noted that he has “plus speed and decent hands but lacks the consistency to play shortstop, profiling as an offensive second baseman.” The 21-year-old switch-hitter has batted .253/.317/.352 in the minors, primarily at the Single-A level.

AL West Notes: A’s, Rangers, Astros

By | at

The Athletics’ promising stable of starters could make right-hander Sonny Gray expendable this year, posits FOX Sports’ Ken Rosenthal (video link). Major leaguers Kendall Graveman, Jharel Cotton, Sean Manaea and Andrew Triggs all look like viable building blocks, while prospects Grant Holmes and last year’s sixth overall pick, A.J. Puk, are among potential future starters within the organization. Gray endured a nightmarish 2016 and is currently on the mend from a lat strain, so his stock surely isn’t where it was when he performed like an ace from 2013-15. Still, Gray’s fairly young (27), affordable ($3.575MM) and controllable via arbitration through the 2019 campaign. If Oakland does place Gray on the block, it could seek outfield help in return, Rosenthal says.

Here’s more from the AL West:

  • The Rangers aren’t inclined to trade corner infielder/outfielder Joey Gallo, whom they view as an important long-term piece, according to Rosenthal. The powerful Gallo has been strong at third base this year in place of the injured Adrian Beltre, who’s 38 and only signed through next season. Even if Gallo exits the lineup when Beltre returns, the 23-year-old could become an everyday player at first base or in the outfield by next season, Rosenthal notes. At that point, free agents-to-be Mike Napoli and Carlos Gomez might be in other uniforms, thus creating room for Gallo. The former big-time prospect has slashed a productive .235/.350/.529 in 40 PAs this year, and while he’s still striking out too much, his 35 percent K rate is a vast improvement over the unsightly 63.3 percent mark he put up in 30 PAs last season.
  • The Astros faced a scary situation in Oakland on Saturday when shortstop Carlos Correa left early after taking a 96 mph fastball from Frankie Montas to the left hand. Fortunately for the Astros and Correa, X-rays only revealed a contusion. “Good news, obviously,” Correa told Brian McTaggart of MLB.com. “I thought it was going to be a lot worse. Obviously, it was a hard-throwing guy and it was a fastball inside. He didn’t give me a chance to get out of the way and I got hit in the hand. Thank God no fracture.” Correa, who’s day-to-day, hopes to return to Houston’s lineup Sunday.
  • Athletics shortstop Marcus Semien has a bone contusion in his right wrist and will undergo an MRI on Monday, tweets Joe Stiglich of NBC Sports California. Semien’s wrist has been an issue since late in the spring, adds Stiglich, and that could at least partially explain his early season power outage. After swatting 27 long balls and posting a .197 ISO last season, Semien has gone homer-less and managed a paltry .057 ISO in 46 plate trips this year.
  • Rangers reliever Keone Kela, demoted to Triple-A on March 31 as a disciplinary measure, is a candidate to rejoin Texas’ bullpen next time the team needs help from the minors, writes Jeff Wilson of the Fort Worth Star-Telegram. “Kela’s never not been an option,” said manager Jeff Banister. “They’ve all been possibilities. It just depends on what you need.” The 23-year-old Kela was excellent as a rookie in 2015, but he took significant steps backward last season and then earned a ticket to Triple-A by showing a lack of effort in a minor league intrasquad game this spring.

Rangers Outright Tanner Scheppers

By | at

The Rangers have announced that they’ve activated righty Andrew Cashner (triceps) from the 10-day DL. To clear roster space, they’ve optioned righty Nick Martinez to Triple-A Round Rock and outrighted righty Tanner Scheppers to Triple-A Round Rock, removing him from their 40-man roster. Cashner is set to make his Rangers debut tonight against the Mariners.

The 30-year-old Scheppers was a first-round pick in 2009 and showed glimpses of potential with the Rangers, routinely throwing in the mid-90s and generally performing well in his first two years in the big leagues, 2012 and 2013. He was the Rangers’ Opening Day starter in 2014, but he ended up missing portions of 2014 and 2015 with elbow and knee injuries. Since then, he’s struggled to reestablish himself in the Rangers’ bullpen, and his peripherals haven’t been nearly as impressive as his velocity. Injuries continued to bother him, as well — he missed much of the 2016 season after having surgery on his left knee. He had begun this season on the 10-day DL with abdominal discomfort and had made two rehab appearances with Round Rock.

West Notes: Dipoto, Richards, Cashner, Bush, Morse, Bradley

By | at

Mark Feinsand of MLB.com provides an interesting interview with Mariners GM Jerry Dipoto that’s well worth a full read. The topics range from the impact of Statcast to Dipoto’s seemingly insatiable appetite for trades.

Here’s more from the game’s western divisions:

  • We checked in earlier tonight on Angels righty Garrett Richards, and there’s more news on that front. GM Billy Eppler says that the current concern is an ongoing lack of strength in Richards’s biceps, as Pedro Moura of the Los Angeles Times reports (Twitter links). Though cervical disc issues apparently aren’t at the root — an MRI came back clean — it seems that’ll need to be resolved before Richards can return to the hill.
  • The Rangers will finally get a chance to see what they have in righty Andrew Cashner. He’s slated to make his first start for the team tomorrow, as Evan Grant of the Dallas Morning News tweets. Cashner, who signed a one-year make-good deal over the winter, was set back by biceps tendinitis in camp.
  • There was other good news on the injury front for the Rangers. As Jeff Wilson of the Fort Worth Star-Telegram writes, key reliever Matt Bush could return to action as soon as this weekend. He has seemingly responded well to a cortisone shot in his shoulder, though the club is waiting a bit longer to make sure he’s pain free before putting him back on the rubber.
  • Giants outfielder Michael Morse is nearly ready to take the field at Triple-A after rehabbing his hamstring, Alex Pavlovic of NBC Sports Bay Area reports on Twitter. Indeed, Morse may be prepared for MLB action in just ten days, per the report. It’s unclear as yet what San Francisco’s plans are for the veteran, but he’d clearly represent an alternative to Chris Marrero if the club decides to make a change. Though Marrero has had a productive game tonight, including his first big league homer, he has struggled out of the gates.
  • The Diamondbacks are still weighing just how to use Archie Bradley, who has shown resurgent form this year, as Nick Piecoro of the Arizona Republic reports. Bradley’s outstanding early work from the bullpen — no runs, ten strikeouts, and just two walks over 6 2/3 frames — has manager Torey Lovullo wondering how best to maximize the former top starting prospect. For now, it seems, Bradley is likely to continue working as a longman, but the skipper suggested that the young righty could begin to enter in higher-leverage spots. It’s worth noting that Bradley is now averaging 95.7 mph with his fastball after sitting just over 92 in his prior two MLB campaigns, though of course that’s probably aided in part by his move to a relief role.

Injury Notes: Kaprielian, Ross, Beltre, Bush, Gutierrez, Bailey, M’s

By | at

Yankees pitching prospect James Kaprielian is weighing whether or not to undergo surgery, GM Brian Cashman told reporters including Erik Boland of Newsday (Twitter links). Cashman didn’t make clear just what surgical options might be on the table for the 23-year-old, who is said to have experienced elbow pain recently, but all the hints suggest it could be a significant injury. “The rehab process has not been successful,” said Cashman, “so he’s facing some decisions.” Kaprielian also dealt with elbow problems last year, limiting his ability to gain minor-league experience, but there were still suggestions that the 2015 first-rounder might factor at the MLB level this year.

Here’s more on some health situations from around the game:

  • The Rangers have provided some updates on several players, all via T.R. Sullivan of MLB.com (links to Twitter). Righty Tyson Ross will need to hold off on his rehab for a bit after experiencing upper back spasms. While it doesn’t appear as if there’s any broader concern, it will slow his timeline by at least a week. Meanwhile, Adrian Beltre’s new calf injury will likely cost him enough time to be measured in weeks rather than days, per assistant GM Mike Daly. Understandably, the club is charting a cautious course with the veteran, who had been nearing his return from calf issues before suffering another strain in a different area of the muscle. Finally, the team will wait to see how setup man Matt Bush responds to an injection before determining whether he’ll need a DL stint for his sore shoulder.
  • Dodgers outfielder Franklin Gutierrez is headed to the 10-day DL with a hamstring strain, as Bill Shaikin of the Los Angeles Times reports (Twitter links). He’ll be replaced for the time being by Trayce Thompson, but skipper Dave Roberts says it’s expected to be only a one-to-three-week layoff.
  • The Angels have placed righty Andrew Bailey on the 10-day DL to rest his inflamed shoulder, per a club announcement. He’ll be replaced on the active roster by fellow righty Daniel Wright. It’s not yet clear just how long Bailey will be down. For Wright, this’ll be his third call-up to the majors; he saw action last year with both the Reds and Angels, working both as a stater and from the pen.
  • Mariners righty Tony Zych could be nearing a return, as Bob Dutton of the Tacoma News Tribune reports, with Steve Cishek not farm behind him. It remains to be seen whether Zych will head to the MLB roster, as he could also be optioned. Manager Scott Servais praised the righty’s form after a sim game, saying he looked “very sharp.”

AL West Notes: Bush, Cashner, Mariners, A’s

By | at

Rangers setup man Matt Bush is headed back to Texas to have the sore AC joint in his shoulder examined and to receive an injection for the pain, per Evan Grant of the Dallas Morning News. While that sounds ominous for an already banged-up Rangers club, Grant notes that the team currently believes that Bush will avoid a trip to the disabled list. Bush dealt with a similar issue at times in 2016, per the report, so it’s not entirely new issue. That said, even a brief absence for Bush thins out a Rangers relief corps that has struggled greatly in the season’s early stages. Closer Sam Dyson has had a nightmarish start to the year, yielding a staggering 11 runs on 11 hits (two homers) and three walks in just three innings of work. Dyson coughed up a five-run lead to the Angels in the ninth inning last night while Bush was deemed “unavailable” by manager Jeff Banister. Given Dyson’s catastrophic meltdown and Bush’s ailing shoulder, it wouldn’t be a surprise to Jeremy Jeffress and/or Tony Barnette get some save opportunities in the near future.

More notes out of Arlington and the rest of the AL West…

  • Rangers right-hander Andrew Cashner feels that he’s ready to join the rotation after throwing five shutout innings in an extended Spring Training game, writes Jeff Wilson of the Fort Worth Star-Telegram. The Rangers, though, have yet to make a decision on whether to activate the oft-injured righty. Texas may elect to give Cashner another rehab outing in an effort to further build up some arm strength, which would make sense given the current state of the bullpen. As Wilson notes, being able to exceed 100 pitches would be preferable in an ideal scenario, as that’d spare the Rangers’ relief corps some extra work. Righties Dillon Gee, Nick Martinez and Eddie Gamboa could make a spot start in the interim, Wilson adds.
  • The Mariners will have a few roster moves to make today, Ryan Divish of the Seattle Times notes (Twitter links). Outfielder Boog Powell is set to be reinstated after receiving an 80-game suspension for a failed PED test late last June, and Seattle will need to open a 40-man spot to accommodate him. Additionally, Divish reports that the Mariners are slated to promote right-hander Evan Marshall from Triple-A Tacoma to get a fresh arm into their ’pen.
  • Though the Athletics opened the season with a closer-by-committee approach, that committee has narrowed to include just two pitchers, manager Bob Melvin said yesterday on MLB Network Radio on SiriusXM (Twitter link). Per Melvin, left-hander Sean Doolittle and right-hander Santiago Casilla will share ninth inning duties and be called upon based on the matchups the A’s are facing heading into the final inning. That means that righties Ryan Madson (last year’s primary closer) and Ryan Dull will each function primarily as setup men.

Adrian Beltre Diagnosed With New Calf Strain

By | at

April 12: Beltre’s MRI revealed a new calf strain (Grade 1), writes Wilson. The Rangers plan to proceed with caution, and it’s possible that Beltre could be out of action into the month of May, Wilson adds. Evan Grant notes that Beltre is likely to be sidelined at least another two weeks, adding that this is the third separate calf injury that Beltre has incurred since mid-February.

Beltre tells reporters that the new strain in his calf is in a different location than the first one by which he was plagued. Manager Jeff Banister tells reporters that the team isn’t putting any timetable on Beltre’s recovery for now. Notably, Banister also added that there won’t be a platoon at third base in his absence; Gallo will get the opportunity to play regularly (via Wilson): “He has earned the opportunity to play. The qualifier to that is there are going to be days, like everybody else, that’s he’s going to need a day.”

April 11: Rangers third baseman Adrian Beltre has suffered a setback in his rehab from a calf injury, Beltre himself told reporters (Twitter links via Jeff Wilson of the Fort Worth Star-Telegram and Evan Grant of the Dallas Morning News). Beltre felt something while running this past Saturday and has already undergone a new MRI to evaluate the issue. “Something isn’t right,” Beltre said (via Grant). “It’s not just tightness.”

[Related: Texas Rangers Depth Chart]

Obviously, that’s an ominous quote from Beltre, who suffered the calf issue late in Spring Training and opened the season on the disabled list. While the team was originally hopeful that the injury wouldn’t last much longer than the 10-day minimum on the new disabled list, today’s news indicates that’s no longer a likely outcome.

Any significant absence for Beltre would be a substantial blow to the Rangers, who already have Andrew Cashner, Jake Diekman, Tyson Ross and Chi Chi Gonzalez on the disabled list. Though Beltre turned 38 a few days ago, he continued to play at an elite level through the 2016 campaign, hitting .300/.358/.521 with 32 homers and excellent glovework at third base last year.

Thus far in 2017, the Rangers have entrusted third base to Joey Gallo in Beltre’s absence. Long one of the top-rated prospects in the game, Gallo’s prodigious power makes him an intriguing and potentially excellent replacement for Beltre, though his struggles in making contact still loom large. The 23-year-old has struck out in 48 percent of his 176 Major League plate appearances, and he whiffed at nearly a 35 percent clip in Triple-A last year. Though Gallo has homered twice through his first 23 plate appearances of the season, he’s also punched out nine times. To this point, he’s hitting .200/.304/.500 in that tiny sample of work.

Transaction Retrospection: The Elvis Andrus Extension

By | at

In early April of 2013, the Rangers struck what was then described by GM Jon Daniels as “an unusual deal” with shortstop Elvis Andrus. Daniels was likely referring to the complicated structure, which included two opt-out opportunities (following the 2018 and 2019 campaigns), but it has proven unusual in other ways.

Apr 5, 2017; Arlington, TX, USA; Texas Rangers shortstop Elvis Andrus (1) throws to first in the fifth inning against the Cleveland Indians at Globe Life Park in Arlington. Mandatory Credit: Tim Heitman-USA TODAY Sports

Opt-out provisions are now fairly common, particularly in large free-agent deals and extensions reached with players who already have significant service time. But contracts of the size of the Andrus deal — which guaranteed him $120MM over eight years (beginning in 2015) — are a rarity for players of that general service time. Andrus, who had already agreed to one prior extension, had just begun his 4+ service-class year. Since his deal was made, just two players with at least three but less than five years of service — i.e., experienced players who aren’t entering a contract year — have cleared $100MM in guaranteed money. Those other deals went to franchise faces Giancarlo Stanton and Freddie Freeman.

Indeed, Andrus looks like something of an outlier when you expand the terms further to include 2+ players and look a bit further back. In addition to the three players noted above, here’s the list of players who scored nine-figure guarantees when they had more than two but less than five years of service (within the time period covered by MLBTR’s Extension Tracker):

Needless to say, these were all players who were (or, at least, were viewed by their organizations as) franchise-level talents. Andrus was certainly on the young side for this group; he was then entering his age-24 campaign. Only Trout and Freeman were younger, the latter only marginally so. And its fair to note that Andrus landed clearly on the low side of the total guarantees included in this somewhat arbitrary list.

Still, it was then and remains surprising to see Andrus in such company. Also, the opt-out opportunities weren’t present in those other contracts, which reduced the team’s upside. He had yet to post even a league-average batting line (and wouldn’t crack that barrier until 2016). And though he did rate as a high-quality fielder and outstanding baserunner, he graded out more as a quality first-division regular than a superstar. Fangraphs and Baseball-Reference each valued his 2011 season as his best, with the former crediting him with 4.0 WAR and the latter pegging the overall value at 4.2 WAR.

The first two years after the agreement weren’t kind to the team. Between 2014 and 2015, Andrus slashed just .261/.312/.345. While he swiped 52 bags, he was gunned down on 24 attempts. And his fielding grades took a precipitous tumble. Entering the 2016 season, Texas was still on the hook for $103MM over the following seven years. And it seemed rather unlikely that Andrus would bail on the contract’s back end.

Things did change for the better last year, however. Though Andrus didn’t recover his standing as a baserunner and gloveman, he did finally break through somewhat at the plate. Over 568 plate appearances, he slashed .302/.362/.439 — representing career-best marks in all three categories and working out to a 112 wRC+. There were some underlying changes at work, many of which represented carryovers from a shift that began the season prior. It was in 2015 that Andrus began to take a more aggressive approach, increasing his swing rate, producing a big drop in his groundball-to-flyball ratio and increasing the number of balls he pulled while largely maintaining his typically excellent contact skills.

Of course, Andrus wasn’t all that good with the bat in 2015. The biggest difference between that season and his strong 2016? Yep, a fifty point jump in BABIP (from .283 to .333). It’s an open question whether 2015 was weighed down by bad luck or whether 2016 was boosted by good fortune — perhaps the answer lies somewhere in the middle — but the Rangers will surely hope it’s the former. Andrus has hit well in the early going in 2017, despite carrying a .278 BABIP, though it’s far too soon to know whether that will continue.

As things stand, Andrus will open the current season with a six-year, $88MM deal that still includes the two opt-out chances. (Andrus can opt out of four years and $58MM or three years and $43MM.) It’s questionable whether he’d have received anything like that on the open market this past winter, though perhaps that depends in part upon how organizations view his current tools and how they value his 2016 season — which B-Ref values at a robust 3.7 WAR, but Fangraphs pegs at only 2.1 WAR.

It seems rather unlikely that the Rangers will get the kind of value they hoped for when they paid Andrus like a premier player. Indeed, they arguably didn’t even receive a fair ROI for the $15MM salaries Andrus took down in each of the past two seasons. But it’s still possible the deal could work out reasonably well over the long run, or even that he’ll find cause to opt out; after all, with two productive years, Andrus could conceivably expect to find yet more money on the open market in advance of his age-30 season.

Photo courtesy of USA Today Sports Images.

Offseason In Review: Texas Rangers

By | at

This is the latest entry in MLBTR’s Offseason In Review series. The full index of Offseason In Review posts can be found here.

Facing a number of high-profile defections and about as many big holes, the Rangers faced a tough task this winter. Their acquisitions are just talented enough to work out well for them, but they’ll need some luck to approach their 95-win total from 2016.

Major League Signings

Trades And Claims

Notable Minor League Signings

Josh Hamilton, James Loney (since released), Travis Snider, Will Middlebrooks, Allen Webster, Anthony Bass, Bobby LaFromboise

Extensions

  • Rougned Odor, 2B: six years, $49.5MM, including $3MM buyout on $13.5MM option for 2023
  • Robinson Chirinos, C: one year (2018), $2.35MM, including $100K buyout on $2.375MM option for 2019

Contract Options

Notable Losses

Ian Desmond, Carlos Beltran, Mitch Moreland, Colby Lewis, Holland

Needs Addressed

Heading into the winter, the Rangers faced a number of potential high-profile defections, including those of Ian Desmond, Carlos Gomez and Carlos Beltran, and a limited amount of cash with which to address them — the Rangers’ budget was somewhat restricted by high-dollar, low-value contracts such as those of Prince Fielder and Shin-Soo Choo, as well as expensive deals for Cole Hamels, Adrian Beltre, Elvis Andrus and Yu Darvish.

In particular, the Rangers needed to replace key players in their outfield, upgrade their rotation and find a solution at first base and/or DH. In their rotation, the Rangers sensibly declined longtime starter Derek Holland’s $11MM option, paying him a $1.5MM buyout after a season in which he posted a 4.95 ERA, 5.6 K/9 and 2.9 BB/9 while struggling with shoulder trouble. They also parted ways with another longtime starter, 37-year-old Colby Lewis, whose 3.71 ERA in 2016 masked lousy peripherals. Lewis remains a free agent.

The free-agent market for starting pitchers was poor, giving the Rangers limited opportunities to find another solid starter to complement Hamels, Darvish and Martin Perez. Instead, they gambled on two interesting former Padres arms, Andrew Cashner and Tyson Ross. Both are relatively young pitchers with tantalizing stuff, but they also both come with major question marks.

Andrew CashnerCashner received $10MM and will enter the Rangers’ rotation as soon as he’s ready, likely sometime late this month. The 30-year-old brings mid-90s heat and a hard slider, but he’s never gotten the sorts of strikeout rates you’d associate with that repertoire, and he’s coming off a season in which he posted a 5.25 ERA, 7.6 K/9 and 4.1 BB/9 while fading down the stretch. It will be up to the Rangers to figure out why. Cashner has used his changeup less and less frequently over the years, and the pitch has been less effective when he’s thrown it; reestablishing that pitch might be a key to reviving his career. As Fangraphs’ Eno Sarris points out, Rangers catcher Jonathan Lucroy might be able to help Cashner with his quality pitch framing. In any case, Cashner’s an interesting gamble, although $10MM seems like a lot to pay given his recent performances. He’ll also begin the season on the DL due to biceps tendinitis.

The Rangers also added Tyson Ross, whose main problem is health. The 29-year-old had back-to-back excellent seasons in San Diego in 2014 and 2015, but pitched only one outing in 2016 due to shoulder trouble, and finally had offseason surgery to relieve thoracic outlet syndrome. The Padres non-tendered him in December, and the Rangers lured him away from the Cubs with a $6MM deal. He isn’t ready yet, but he’s progressed to throwing bullpens and simulated games, and could be ready to join the Rangers early in May. It remains to be seen whether the Rangers will be getting the pitcher who struck out a batter an inning and posted ground-ball rates in the 60% range in 2014 and 2015. Ross can help them if he’s even half that good, but it’s difficult at this point to project with any certainty that he will be.

The Rangers thus began the season with a rotation that features neither of the key starting pitchers they acquired. Darvish, Hamels, Perez and A.J. Griffin (who struggled to a 5.07 ERA, 8.1 K/9 and 3.5 BB/9 in 2016 after missing two full seasons to injury) will comprise the initial rotation, with Cashner perhaps joining in mid-April when the team needs a fifth starter. The Rangers initially signed Dillon Gee to a minor-league deal, and then, after he opted out, re-signed him to a big-league contract and optioned him to Triple-A; he represents an alternative if Cashner isn’t ready to go. Given the considerable question marks surrounding Cashner, Ross, Griffin and Gee (and, if we want to get really pessimistic, Perez, who posted a very shaky 4.7 K/9 last season), the Rangers’ rotation still looks iffy, although it’s also easy to see the upside if Cashner and Ross pan out.

In the outfield, the Rangers lost Desmond to the Rockies, who agreed to pay him $70MM over five years. The Rangers, meanwhile, received the No. 29 pick in this year’s draft as compensation. The Rangers had interest in Desmond, but were wise not to match the Rockies’ offer — Desmond’s resurgence in 2016 was fueled by a career-best .350 BABIP, and he’s already 31.

Instead, the Rangers retained another outfielder, re-signing Carlos Gomez to a short-term deal to man center field. Gomez’s career seemed to be falling apart when the Astros released him last August, but he caught on with the Rangers down the stretch and batted .284/.362/.543, numbers worthy of his brilliant 2013-2014 run with Milwaukee. That sort of production probably won’t continue, but for a mere $11.5MM, the Rangers can get a good deal even if Gomez’s offense tails off. His hitting is hard to predict, and his 30.0% strikeout rate for the 2016 season is a bad sign, but he has defensive and baserunning value going for him, plus a bit of home-run power. All things considered, he seems good for about two wins above replacement, which would rather easily make him worth the value of his contract.

For first base and DH, the Rangers turned to another familiar face, that of Mike Napoli. The Rangers faced the loss not only of Beltran, but also longtime first baseman Mitch Moreland, whose production faded in 2016. Minor-league über-slugger Joey Gallo looked like an obvious candidate to take over at first, but the Rangers made clear at the beginning of the offseason that they felt the 23-year-old Gallo, who whiffed in a ghastly 34.6% of his plate appearances at Triple-A last year, ought to start 2017 in the minors. (Gallo began the season in the Majors anyway, taking over at third for Beltre, who is nursing a calf injury.)

Napoli is coming off a 34-homer season in Cleveland. The 35-year-old has always fared well in Texas — he had two of the best years of his career there in 2011 and 2012, and also was productive after the Red Sox dealt him to the Rangers in August 2015. It’s not a given his third stint with the team will go as well, given his age and his seemingly limited ability to hit for average. He batted just .248 in 2014, .227 in 2015 and .239 in 2016, and if his ability to make contact declines at all, he might have trouble hitting enough homers to compensate. As with the Gomez deal, though, it’s hard to argue with the limited commitment the Rangers made, coughing up only $11MM guaranteed and getting a 2018 team option in the deal as well.

The Rangers also exercised Lucroy’s $5.25MM 2017 option (probably the easiest move they made this winter), and extended backup Robinson Chirinos. Chirinos’ extension bought out his 2018 season, which would have been his last season of arbitration eligibility, for just $2.35MM, likely less than he would have gotten had he been even modestly productive in 2017. The Rangers also received a cheap option for 2019, giving them a couple years of flexibility as they prepare for Lucroy’s possible departure to free agency next winter. Chirinos had never been paid more than $1.55MM in a season prior to the extension, and, at age 32, might never have gotten another shot at a multiyear, multimillion-dollar contract. His new deal thus provides him with a bit of financial security.

Questions Remaining

The Rangers never did acquire another player to help at DH, and it appears they’ll have Choo soak a number of plate appearances there. In a vaccum, that makes sense — Choo has rated as a below-average outfield defender in the past several seasons, and he’s had health problems to boot. With Nomar Mazara slated for the bulk of the time in right, that leaves left field open to one of the most wide-open time shares in baseball.

Delino DeShields arguably sits atop the depth chart at left field, which seems like a questionable proposition. DeShields is coming off an outstanding spring in which he posted a .442 OBP, but he’s coming off a miserable 2016 season in which he batted just .209/.275/.313. At just 24, DeShields is young enough to improve, and he’ll certainly make the Rangers’ defense better. But his bat is a question mark. Neither Ryan Rua nor Drew Robinson have established a track record of offensive production at the major league level, but they’ll also factor in the mix.

Then, there’s Jurickson Profar, once an elite prospect and now something of a super-utility option. Though there was reported trade interest over the winter, Texas elected to hang onto Profar to see if he can restore some of his lost luster. He will participate in the game of musical chairs in left and might also step into the infield wherever a need arises. Gallo, too, could theoretically shift to the corner outfield in addition to seeing time in the corner infield or at DH, depending upon how the season progresses. For both of these top prospects, it’s something of a make-or-break year for their futures with the Rangers.

Then there’s the Rangers’ pitching staff. It’s always hard to know how a bullpen will perform, but the Rangers’ looks fine — their 2016 ’pen didn’t rate well overall, but they’re returning most of the relievers (including Sam Dyson, Matt Bush, Tony Barnette and Alex Claudio) who were key to their second half, when their bullpen did an outstanding job keeping the ball on the ground and were very effective overall. Another key reliever, Jake Diekman, will be out until at least the All-Star Break after having colon surgery. Jeremy Jeffress will need to keep his off-field issues in check to play his expected role; if he can do that and remain effective, then either he or Bush would represent alternatives at the closer role if Dyson’s early struggles continue.

They’ll have to get the ball to those pitchers, though, and their rotation looks like it could quickly boil down to Hamels, Darvish and then a bunch of uncertainties, particularly if Cashner and Ross don’t reemerge.

Deal Of Note

"<strongLate in Spring Training, the Rangers announced that they’d signed second baseman Rougned Odor to a six-year, $49.5MM deal with a club option for 2023. The deal buys out what would have been Odor’s first two free agent seasons, with an option for a third.

The deal is roughly comparable to recent six-year, one-option extensions for fellow second basemen Jason Kipnis and Matt Carpenter, who received $52.5MM and $52MM, respectively, when they had between two and three years of service time. It’s also interesting to compare Odor’s deal to that of another infielder’s recent extension: that of Jose Ramirez, who received just $26MM over five years and gave up two option years. Even if the Indians exercise Ramirez’s first option, he’ll only receive a total of $35MM, far less than Odor, Kipnis or Carpenter received.

It’s debatable whether Odor will be as valuable as Kipnis or Carpenter have proven to be — Odor produced a mere .296 OBP and questionable defensive numbers in 2016. But the outlier here is Ramirez’s contract, not Odor’s, and that ultimately isn’t surprising. Kipnis, Carpenter, Ramirez and Odor were all early enough in their careers at the time of their extensions that many of the yearly salaries their extensions covered would have been governed by the arbitration process, which values counting stats. While Odor doesn’t have the overall track record Kipnis or Carpenter did, his 33-homer total in 2016, if sustained, probably would have gotten him paid at a similar rate. That’s particularly likely since the Kipnis and Carpenter contracts are both now three years old.

Ramirez, meanwhile, had two uneven years before his breakout 2016 and hasn’t posted outstanding counting stats in any category. As a player, I’d probably prefer Ramirez to Odor, due to Ramirez’s defense and versatility, as well as the greater likelihood that he’ll continue to reach base at a palatable rate. But it makes sense that Odor was the one who got the big contract.

These are, of course, different questions than whether the Rangers should have extended Odor. Odor whiffed seven times as often as he walked in 2016, a worrying sign. He only recently turned 23, though, so there’s plenty of room for growth. And even if his career stagnates, his deal is still fairly cheap in the grand scheme of things despite being considerably more expensive than Ramirez’s, and his positional value, power and age insulate the Rangers somewhat against the possibility that the deal will go south.

Overview

The Rangers’ 95-win 2016 season was built on shaky ground — they only scored eight more runs than they allowed. This year, their weaknesses look fairly obvious, particularly in their rotation. They have enough marquee talent (including Hamels, Darvish, Beltre, and Lucroy, potentially along with players like Odor or young outfielder Nomar Mazara) to contend if things go well, however. Within that context, their signings of Cashner and Ross this offseason look like Hail Mary passes — those gambles don’t appear incredibly likely to produce huge dividends, but could be decisive for the team if they do. The Rangers might have a hard time topping the Astros this season. But it’s easy to see how they could.

If things don’t go as hoped, though, the front office will increasingly face questions about how to handle the next offseason. While the Rangers could revisit extension talks with Darvish and Lucroy, or pursue them on the open market, efforts at new deals fizzled this spring. That could leave two very notable holes on the roster at the end of the 2017 season.

How would you rate the Rangers’ offseason moves? (Link for app users.)

Photos courtesy USA Today Sports Images.

DL Notes: Howell, Beltre, Rickard, Johnson, Otani

By | at

Here’s the latest injury news from around the baseball world…

  • The Blue Jays placed southpaw J.P. Howell on the 10-day DL with a sore shoulder, with righty Dominic Leone recalled from Triple-A to take Howell’s place on the roster.  (Sportsnet’s Shi Davidi was among those to report the news.)  Signed to a one-year, $3MM deal in the offseason, Howell has a 54.00 ERA over one-third of an inning in his brief Jays tenure, thanks to an ugly outing on Friday that saw him allow two runs without recording an out.  Howell underwent labrum surgery in 2010 but his shoulder hasn’t had any issues since; the durable reliever has averaged 64 games per season from 2012-16.  With Howell sidelined, Aaron Loup is the only left-hander in the Toronto bullpen.  [Updated Blue Jays roster at Roster Resource]
  • Adrian Beltre is eligible to return from the 10-day DL today but the Rangers have decided against activating the star third baseman, Evan Grant of the Dallas Morning News reports.  Beltre has been out of action due to a right calf strain and isn’t quite ready to play, though he has participated in batting practice and some running drills.  Joey Gallo has been filling in at third in Beltre’s absence.
  • Orioles outfielder Joey Rickard is headed to the 10-day DL due to a sprained left middle finger, manager Buck Showalter told MASNsports.com’s Roch Kubatko and other reporters.  Rickard suffered the injury sliding into second base yesterday.  The O’s had a ready-made replacement for Rickard on the 25-man roster, as Wade Miley was activated from the 10-day DL for his scheduled start this afternoon against the Yankees.  There was some question over how Baltimore would find a 25-man roster spot for Miley upon his return, and according to Showalter, Rickard wouldn’t have been optioned had he been healthy.  With Rickard out, Trey Mancini and Craig Gentry will be the right-handed hitting sides of Baltimore’s corner outfield platoons, with Hyun Soo Kim and Seth Smith providing the lefty bats.  [Updated Orioles roster at Roster Resource]
  • Showalter also told media that Chris Johnson suffered a broken bone in his forearm after being hit by a pitch during a Triple-A game yesterday.  Johnson is expected to miss six to eight weeks.  The Orioles signed Johnson to a minor league deal this winter, and then released and re-signed the veteran to a fresh contract at the end of Spring Training.  The opt-out dates within Johnson’s contract (if any) aren’t known, though this lengthy absence could likely impact his decision about staying in Baltimore’s organization.
  • In notable international injury news, Shohei Otani will miss approximately six weeks due to a strain in his left thigh muscle, The Associated Press reports.  Otani suffered the injury trying to beat out an infield single, and as the AP piece notes, “the injury will add further debate to Otani’s insistence on batting as well as pitching.”  The two-way star is both Japan’s best pitcher and a very promising hitter, posting a 1.004 OPS with 22 homers over 382 PA last season for the Nippon Ham Fighters and is off to a blistering start in his first eight games this season.  (Otani has yet to pitch in 2017.)  Otani’s professional future is the subject of wide interest on both sides of the Pacific, as the 22-year-old is reportedly planning to come to the Major League Baseball in 2018.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top